EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer ( EXOSCOL01 ): A Pilot Case–Controlled Study Focusing on MMP14 Potential

Mickaël Barhoum, Sylvie Brassart-Pasco, Aurélie Dupont-Deshorgue, Aurore Thierry, Lukshe Kanagaratnam, Bertrand Brassart, Fidy Ramaholimihaso, Damien Botsen, Claire Carlier, Mathias Brugel, Marine Perrier, Laurent Ramont iD und 1 weitere

Journal of Clinical Laboratory Analysis · 2025

DOI: 10.1002/jcla.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Mickaël Barhoum und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Digestive Oncology, Université de Reims Champagne-Ardenne, Reims, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Exosomes, Matrix Metalloproteinase 14. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Structure Fédéractive de Recherche CAP Santé, The Programme Hospitalier de Recherche Clinique Interrégional 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is the second leading cause of cancer‐related death worldwide. The French CRC screening campaign is based on fecal immunochemical tests (FIT), confirmed by colonoscopy, an invasive procedure with a poor participation rate. This study aimed to compare the expression of circulating exosomal proteins (MMP14, β1‐Integrin subunit, β3‐Integrin subunit, and α1(I) Collagen chain) in patients with CRC or adenomas.

Methods

A total of 71 patients were recruited, including 24 controls (normal colonoscopy), 11 patients with adenoma, and 36 with CRC. Plasmatic exosomal protein expression was measured by western blot analysis and reported to either protein or exosome content.

Results

The three groups were comparable regarding clinical characteristics. A significant difference was observed for MMP14 relative expression ( p = 0.0007), MMP14 expression reported to exosomal protein content ( p = 0.0003), and MMP14 expression reported to exosome content ( p = 0.0005). These three parameters were significantly higher in patients with adenoma vs. control patients ( p = 0.0013, p = 0.0004, and p = 0.0003, respectively). Only MMP14 relative intensity was significantly higher in the CRC group vs. the control group ( p = 0.0018).

Conclusions

Exosomal MMP14 is a promising early diagnostic biomarker for CRC and adenoma. These preliminary results warrant confirmation in larger studies using quantitative measurements such as ELISA or flow cytometry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorExosomesMatrix Metalloproteinase 14HumansMaleFemalePilot ProjectsMiddle AgedCase-Control StudiesAgedAdenoma

Stichwörter der Autor:innen

BiomarkersEXOSCOL01colorectal neoplasmsexosomesintegrinsmatrix metalloproteinases

Substanzen

Biomarkers, TumorMatrix Metalloproteinase 14MMP14 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology and Digestive Oncology, Université de Reims Champagne-Ardenne, Reims, France.
  • Université de Reims Champagne-Ardenne, CNRS, MEDyC Research Unit, UMR CNRS/URCA 7369, Reims, France.
  • CHU Reims, Unité d'Aide Méthodologique, Université de Reims Champagne-Ardenne, VieFra UR 3797, Reims, France.
  • Department of Medical Oncology, Godinot Cancer Institute, Reims, France.
  • Gastroenterology and Digestive Oncology Department, Centre Hospitalier Côte Basque, Bayonne, France.
  • Biochemistry, Pharmacology and Toxicology Department, CHU Reims, Reims, France.

ORCID-Profile: Laurent Ramont

Förderung

  • The Structure Fédéractive de Recherche CAP Santé
  • The Programme Hospitalier de Recherche Clinique Interrégional 2023

Zitieren

APA

Barhoum, M., Brassart-Pasco, S., Dupont-Deshorgue, A., Thierry, A., Kanagaratnam, L., Brassart, B., Ramaholimihaso, F., Botsen, D., Carlier, C., Brugel, M., Perrier, M., Ramont, L., & Bouché, O. (2025). Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer ( EXOSCOL01 ): A Pilot Case–Controlled Study Focusing on MMP14 Potential. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70016

Vancouver

Barhoum M, Brassart-Pasco S, Dupont-Deshorgue A, Thierry A, Kanagaratnam L, Brassart B, et al. Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer ( EXOSCOL01 ): A Pilot Case–Controlled Study Focusing on MMP14 Potential. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70016

BibTeX
@article{Barhoum2025,
  author = {Barhoum, Mickaël and Brassart-Pasco, Sylvie and Dupont-Deshorgue, Aurélie and Thierry, Aurore and Kanagaratnam, Lukshe and Brassart, Bertrand and Ramaholimihaso, Fidy and Botsen, Damien and Carlier, Claire and Brugel, Mathias and Perrier, Marine and Ramont, Laurent and Bouché, Olivier},
  title = {Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer ( EXOSCOL01 ): A Pilot Case–Controlled Study Focusing on MMP14 Potential},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2025},
  doi = {10.1002/jcla.70016}
}
Kostenlos starten →